Results 31 to 40 of about 19,518 (183)

Genetic Etiologies of Dystonia with Anarthria/Aphonia

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Dystonia with anarthria and/or aphonia (DAnAp) represents a distinctive phenotype manifesting across lifespan. Frequently associated with genetic disorders, early recognition is critical for diagnosis and management. Objectives To provide practical recommendations for the clinical evaluation of patients with DAnAp, enhancing ...
Anika Ménétrey, Eriberto Rayco, Maziar Emamikhah Abarghouei, Susan H. Fox, Anthony E. Lang, George M. Ibrahim, Carolina Gorodetsky, Christos Ganos   +7 more
wiley   +1 more source

Intersection of systemic lupus erythematosus and autoimmune thyroid disease: Shared pathophysiology, epidemiology, diagnosis, and management

Rheumatology &Autoimmunity, EarlyView.
A proposed mechanistic framework of systemic lupus erythematosus (SLE) and autoimmune thyroid disease (AITD) pathogenesis. In Stage 1, genetically susceptible individuals harbor risk variants within major histocompatibility complex (HLA) and non‐HLA loci that impair central and peripheral immune tolerance mechanisms within the thymic and peripheral ...
Elisa Elisa, Awalia Awalia, Deasy Ardiany, Henry Sutanto   +3 more
wiley   +1 more source

Twenty-year trend of thyrotoxicosis and thyrotoxic periodic paralysis: a population-based cohort study

European Thyroid Journal
Objective: Thyrotoxic periodic paralysis (TPP) is a rare but potentially lethal complication of thyrotoxicosis. Absence of large cohorts limits the conduct of epidemiology studies.
Gloria Hoi-Yee Li, Ching-Man Tang, Ray Shing-Hin Li, Grace Mengqin Ge, Annie Wai-Chee Kung, Kathryn Choon-Beng Tan, Elaine Yun-Ning Cheung, Ching-Lung Cheung   +7 more
doaj   +1 more source

Calculation of the cut-off and evaluation of the dynamics of natriuretic peptide for optimization the management of comorbid patients with thyrototoxicosis and heart failure

Медицинский вестник Юга России, 2018
Objective: to determine the cut-off of natriuretic peptide for optimization dyagnosis heart failure in comorbid patients with thyrotoxicosis, to assess the dynamics of this indicator during therapy.Materials and methods: 111 patients (58,3±5,6 years) were
E. V. Pashchenko, A. I. Chesnikova, V. I. Kudinov, V. P. Terentyev, O. E. Kolomatskaya   +4 more
doaj   +1 more source

Immune checkpoint inhibitor‐induced arrhythmias: Mechanistic insights from clinical and preclinical studies

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but their efficacy continues to be limited by immune‐related adverse events. Among these, ICI‐induced cardiac arrhythmias are increasingly recognised as a major adverse reaction, encompassing a broad spectrum of clinical phenotypes, including conduction blocks, atrial fibrillation and
Anand R. Ramalingam, Zoltán Márton Köhler, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Transient non rate related left bundle branch block in thyrotoxicosis: A case report

Proceedings of Singapore Healthcare
Thyrotoxicosis is a common condition that is associated with cardiovascular complications. The most common complications that occurs are heart failure and cardiac arrhythmias. Cardiac arrhythmias due to thyrotoxicosis negatively affect the cardiovascular
Nur Izat Muhamad, Rajiv Subramaniam, Mohd Khairi Othman, Zurkurnai Yusof, Wan Izani Wan Mohamed, W Yus Hanif W Isa   +5 more
doaj   +1 more source

Gynecomastia as a presenting symptom of Graves’ disease in a 49-year-old man

Endocrinology, Diabetes & Metabolism Case Reports, 2021
Gynecomastia is a symptom with a potential high disease burden. It has a variety of underlying causes, such as malignant, drug-related or hormonal. The presence of gynecomastia can be explained in thyrotoxicosis due to a concomitant disbalance of sex ...
N Mohammadnia, S Simsek, F Stam
doaj   +1 more source

Diagnostic Options in Graves' or Non‐Graves' Thyrotoxicosis: A Review for Clinical Practice

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Distinguishing Graves' disease (GD) from the other causes of thyrotoxicosis is essential for appropriate management. The clinical phenotype of GD has evolved over time and is currently more heterogenous and milder than in the past. Consequently, the differential diagnosis of thyrotoxicosis is often challenging.
Lorenzo Scappaticcio, Pierpaolo Trimboli, Paola Caruso, Chiara Porcellini, Daniela Forestiere, Maria Ida Maiorino, Katherine Esposito, Giuseppe Bellastella   +7 more
wiley   +1 more source

Ultrastructural liver changes in the experimental thyrotoxicosis

Polish Journal of Pathology, 2017
Aim of the study is to evaluate ultrastructural changes of rat liver in experimental thyrotoxicosis. For the study, 36 male rats have been utilized, weighing approximately 150-190 g, which were divided into three groups: the first, control group (12 ...
Nadiya Vasylivna Pasyechko, Iryna Ihorivna Kuleshko, Veronika Mykolaiivna Kulchinska, Liudmyla Valeriivna Naumova, Iryna Volodymyrivna Smachylo, Anzhela Olehivna Bob, Liudmyla Volodymyrivna Radetska, Mykhailo Yevhenovych Havryliuk, Olha Mykolaiivna Sopel, Liudmyla Petrivna Mazur   +9 more
doaj   +1 more source

Psychotic depression associated with Graves' disease: A case report on treatment prioritization

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 4, December 2026.
Abstract Background Graves' disease can be accompanied by psychiatric symptoms, including affective and psychotic manifestations. When a well‐defined psychiatric syndrome occurs concurrently with a medical illness, determining whether it is directly attributable to the medical condition or represents an independent psychiatric disorder precipitated by ...
Ayumu Kocha, Aya Akaba, Nozomi Sawasaki, Shinobu Seno, Naoya Hara, Taro Minato, Atsuo Nakagawa, Hiroki Kocha   +7 more
wiley   +1 more source